Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy of Atomoxetine Therapy Versus Placebo for Cognitive Late Effects

This study has been withdrawn prior to enrollment.
Sponsor:
Collaborator:
Eli Lilly and Company
Information provided by:
Temple University
ClinicalTrials.gov Identifier:
NCT00255138
First received: November 15, 2005
Last updated: October 28, 2008
Last verified: October 2008
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given